The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Gastrointestinal obstruction 2
SANDOSTATIN LAR DEPOT Gingival swelling 2
SANDOSTATIN LAR DEPOT Glossitis 2
SANDOSTATIN LAR DEPOT Gynaecomastia 2
SANDOSTATIN LAR DEPOT Haemoglobin increased 2
SANDOSTATIN LAR DEPOT Heart valve stenosis 2
SANDOSTATIN LAR DEPOT Hepatic haemorrhage 2
SANDOSTATIN LAR DEPOT Hepatic necrosis 2
SANDOSTATIN LAR DEPOT High density lipoprotein increased 2
SANDOSTATIN LAR DEPOT Hyperaesthesia 2
SANDOSTATIN LAR DEPOT Hypopituitarism 2
SANDOSTATIN LAR DEPOT Hypothermia 2
SANDOSTATIN LAR DEPOT Incision site complication 2
SANDOSTATIN LAR DEPOT Incorrect drug administration duration 2
SANDOSTATIN LAR DEPOT Increased viscosity of upper respiratory secretion 2
SANDOSTATIN LAR DEPOT Infective spondylitis 2
SANDOSTATIN LAR DEPOT Injection site cyst 2
SANDOSTATIN LAR DEPOT Injection site extravasation 2
SANDOSTATIN LAR DEPOT Injection site hypersensitivity 2
SANDOSTATIN LAR DEPOT Insulinoma 2

Total Records: 2,045     Number of Pages: 103